Form 4: Analog Devices CEO Executes Stock Option Exercise and Sale
Statement of Changes in Beneficial Ownership
Analog Devices Chair and CEO Vincent Roche exercised 10,000 stock options and sold the resulting shares under a pre-established 10b5-1 trading plan.
Summary
- Vincent Roche, Chair and CEO of Analog Devices, exercised 10,000 non-qualified stock options at a strike price of $94.41.
- Following the exercise, the acquired shares were sold at an average price of $397.91 per share.
- The transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on May 23, 2025.
- Post-transaction, Roche maintains direct ownership of 187,537.875 shares and indirect ownership of 23,515 shares via a Grantor Retained Annuity Trust.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction was pre-planned and represents routine executive financial management rather than a reaction to company performance.
Positives
- The transaction was conducted under a pre-planned 10b5-1 arrangement, indicating the sale was not based on non-public information.
- The CEO maintains a significant equity stake in the company, aligning interests with shareholders.
Negatives
- The transaction represents a divestment of 10,000 shares by the company's top executive.
Risks
- Executive stock sales can sometimes be perceived negatively by the market, regardless of the existence of a 10b5-1 plan.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Industry Context
StockSavvy.ai notes that executive stock sales via 10b5-1 plans are standard corporate practice for liquidity and diversification, and generally do not signal a change in company fundamentals or management confidence.
Comparison to Industry Standards
- The use of 10b5-1 plans is the industry standard for executives to sell shares while avoiding potential insider trading liability.
- The scale of the sale relative to the CEO's total holdings is minor, which is consistent with typical executive compensation and wealth management strategies.
Stakeholder Impact
- Minimal impact on shareholders as the sale was executed through a pre-arranged plan.
Key Dates
| Date | Description |
|---|---|
| 2024-10-03 | Date of the Vincent Roche 2024 Grantor Retained Annuity Trust. |
| 2025-05-23 | Date the 10b5-1 trading plan was adopted. |
| 2026-05-01 | Date of the option exercise and share sale transaction. |
| 2030-03-11 | Expiration date of the exercised stock options. |
Keywords
Analog Devices, ADI, Insider Trading, Form 4, Vincent Roche, Stock Options, 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.